Back to 
CITADEL ADVISORS LLCNMNMTC
CITADEL ADVISORS LLCNMNMTC1 quarters
Position history for CITADEL ADVISORS LLC's holdings in NEUROONE MED TECHNOLOGIES CO
CITADEL ADVISORS LLC holds 15,032 shares of NMTC (NEUROONE MED TECHNOLOGIES CO), worth $45,697 as of 2026-Q2. This is a new position.
Current Value
$45,697
Current Shares
15,032
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of NMTC: VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD FIDUCIARY TRUST CO, BlackRock, Inc.